체외수정 시장 : 제품 유형, 기술, 사이클 유형, 최종사용자별 - 세계 예측(2025-2030년)

The In-Vitro Fertilization Market was valued at USD 13.09 billion in 2023, expected to reach USD 14.13 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 22.61 billion by 2030.

In-vitro fertilization (IVF) is a pivotal component of assisted reproductive technology, involving egg and sperm extraction for fertilization outside the human body, subsequently facilitating embryo transfer into the uterus. The necessity of IVF stems from increased infertility rates due to factors like advanced maternal age, lifestyle changes, and various medical conditions affecting reproductive health. This procedure is applied across global fertility clinics, hospitals, and research laboratories, serving couples with infertility issues, individuals desiring to preserve fertility, and LGBTQ+ families seeking parenthood. The end-use scope is diverse, spanning patient treatment to fertility research and genetic testing.

Market growth is driven by the increasing prevalence of infertility, advancements in IVF treatments, and rising societal acceptance. Technological strides like embryo biopsy for genetic disease prevention and automation in lab processes enhance the efficacy and accessibility of IVF. Additionally, emerging markets in Asia-Pacific and Latin America present untapped opportunities due to improved healthcare infrastructure and shifting demographics. Key recommendations include investing in personalized medicine approaches and expanding fertility preservation services. However, challenges persist, primarily regulatory hurdles, high procedural costs, and ethical concerns, which may impact market adoption rates and accessibility.

Given these dynamics, fostering innovation is essential; areas such as artificial intelligence application for embryo selection and non-invasive fertility diagnostics represent promising advancements. Similarly, enhancing patient-centric services could drive business growth amid increasing competition. The market is highly dynamic and competitive, characterized by collaborations and mergers seeking technological and geographical expansion. Future research should focus on improving IVF outcomes and reducing costs, addressing the socio-cultural challenges through awareness campaigns, and striking a balance between innovation and ethical practice to maintain consumer trust. With strategic focus and leveraging cutting-edge technologies, stakeholders in the IVF market can harness its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Fertilization Market

The In-Vitro Fertilization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of infertility all across the world owing to increased inclination toward unhealthy lifestyles
  • Government initiatives and reimbursement policies to promote IVF treatments
• Market Restraints
  • Low success rate to IVF treatment
• Market Opportunities
  • Introduction of artificial intelligence and machine learning in IVF treatments
  • Rising trend of individuals seeking IVF treatments & fertility tourism
• Market Challenges
  • Ethical concern in society for acceptance of IVF

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Fertilization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Fertilization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Fertilization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Fertilization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Fertilization Market

A detailed market share analysis in the In-Vitro Fertilization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Fertilization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Fertilization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Fertilization Market

A strategic analysis of the In-Vitro Fertilization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Fertilization Market, highlighting leading vendors and their innovative profiles. These include Boston IVF, Cook Medical Inc., CooperSurgical Inc., FUJIFILM Irvine Scientific, Genea Biomedx Pty Ltd., Hamilton Thorne, Inc., INVO Bioscience, Inc., IVFtech ApS, Kitazato Corporation, Laboratoire CCD, Merck KGaA, Nidacon International AB, Nikon Corporation, Thermo Fisher Scientific Inc., and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Fertilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Reagents & Media, Services, and Software. The Instruments is further studied across Cryosystems, Imaging Systems, Incubators, Micromanipulator Systems, Ovum Aspiration Pumps, and Sperm Separation Systems. The Reagents & Media is further studied across Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, and Semen Processing Media. The Services is further studied across Egg & Embryo Banking, Fresh Donor Services, and Frozen Donor Services.
• Based on Types, market is studied across Conventional IVF, Intracytoplasmic Sperm Injection (ICSI), IVF using Donor Eggs or Donor Sperm, and Mini IVF.
• Based on Technology, market is studied across Intra-Cytoplasmic Sperm Injection and Preimplantation Genetic Diagnosis.
• Based on Cycle Type, market is studied across Donor Egg IVF Cycles, Fresh IVF Cycles (Non-Donor), and Thawed IVF Cycles (Non-Donor).
• Based on End User, market is studied across Clinical Research Institutes, Cryobanks, Fertility Clinics, and Hospitals & Surgical Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of infertility all across the world owing to increased inclination toward unhealthy lifestyles
    • 5.1.1.2. Government initiatives and reimbursement policies to promote IVF treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Low success rate to IVF treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of artificial intelligence and machine learning in IVF treatments
    • 5.1.3.2. Rising trend of individuals seeking IVF treatments & fertility tourism
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concern in society for acceptance of IVF
• 5.2. Market Segmentation Analysis
  • 5.2.1. Types: Growing preference for conventional IVF owing to its higher probability of success
  • 5.2.2. End User: Significant usage of in-vitro fertilization in fertility clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. In-Vitro Fertilization Market, by Product

• 6.1. Introduction
• 6.2. Instruments
  • 6.2.1. Cryosystems
  • 6.2.2. Imaging Systems
  • 6.2.3. Incubators
  • 6.2.4. Micromanipulator Systems
  • 6.2.5. Ovum Aspiration Pumps
  • 6.2.6. Sperm Separation Systems
• 6.3. Reagents & Media
  • 6.3.1. Cryopreservation Media
  • 6.3.2. Embryo Culture Media
  • 6.3.3. Ovum Processing Media
  • 6.3.4. Semen Processing Media
• 6.4. Services
  • 6.4.1. Egg & Embryo Banking
  • 6.4.2. Fresh Donor Services
  • 6.4.3. Frozen Donor Services
• 6.5. Software

7. In-Vitro Fertilization Market, by Types

• 7.1. Introduction
• 7.2. Conventional IVF
• 7.3. Intracytoplasmic Sperm Injection (ICSI)
• 7.4. IVF using Donor Eggs or Donor Sperm
• 7.5. Mini IVF

8. In-Vitro Fertilization Market, by Technology

• 8.1. Introduction
• 8.2. Intra-Cytoplasmic Sperm Injection
• 8.3. Preimplantation Genetic Diagnosis

9. In-Vitro Fertilization Market, by Cycle Type

• 9.1. Introduction
• 9.2. Donor Egg IVF Cycles
• 9.3. Fresh IVF Cycles (Non-Donor)
• 9.4. Thawed IVF Cycles (Non-Donor)

10. In-Vitro Fertilization Market, by End User

• 10.1. Introduction
• 10.2. Clinical Research Institutes
• 10.3. Cryobanks
• 10.4. Fertility Clinics
• 10.5. Hospitals & Surgical Centers

11. Americas In-Vitro Fertilization Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific In-Vitro Fertilization Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa In-Vitro Fertilization Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Kerala's Sabine Hospital secures USD 50M from investors
  • 14.3.2. Gameto raises USD 33 million in Series B to advance IVF technology
  • 14.3.3. Birla Fertility and IVF expands into South India with acquisition of ARMC IVF Fertility Centre
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Boston IVF
• 2. Cook Medical Inc.
• 3. CooperSurgical Inc.
• 4. FUJIFILM Irvine Scientific
• 5. Genea Biomedx Pty Ltd.
• 6. Hamilton Thorne, Inc.
• 7. INVO Bioscience, Inc.
• 8. IVFtech ApS
• 9. Kitazato Corporation
• 10. Laboratoire CCD
• 11. Merck KGaA
• 12. Nidacon International AB
• 13. Nikon Corporation
• 14. Thermo Fisher Scientific Inc.
• 15. Vitrolife Sweden AB